Table 1. Baseline Characteristics of the Included Population Across Comparison Groups for Which the Pooled Estimate Were Adjusted.
| NLR < 10 | NLR > 11 | Significance | LCR < 10 | LCR > 11 | Significance | |
|---|---|---|---|---|---|---|
| Age | 63.6 years | 61.6 years | P = 0.71 | 62.6 years | 63.7 years | P = 0.65 |
| Sex | ||||||
| Men | 66 (80.50%) | 16 (19.50%) | P = 0.167 | 23 (27.70%) | 60 (72.30%) | P = 0.04 |
| Women | 75 (88.20%) | 10 (11.80%) | 13 (14.90%) | 74 (85.10%) | ||
| DM | ||||||
| No | 92 (85.20%) | 16 (14.80%) | P = 0.716 | 23 (21.10%) | 86 (78.90%) | P = 0.974 |
| Yes | 49 (83.10%) | 10 (16.90%) | 13 (21.30%) | 48 (78.70%) | ||
| HTN | ||||||
| No | 48 (80.00%) | 12 (20.00%) | P = 0.237 | 14 (23.30%) | 46 (76.70%) | P = 0.611 |
| Yes | 93 (86.90%) | 14 (13.10%) | 22 (20.00%) | 88 (80.00%) | ||
| CAD | ||||||
| No | 114 (82.60%) | 24 (17.40%) | P = 0.16 | 30 (21.60%) | 109 (78.40%) | P = 0.784 |
| Yes | 27 (93.10%) | 2 (6.90%) | 6 (19.40%) | 25 (80.60%) | ||
| CKD | ||||||
| No | 114 (83.80%) | 22 (16.20%) | P = 0.65 | 28 (20.30%) | 110 (79.70%) | P = 0.557 |
| Yes | 27 (87.10%) | 4 (12.90%) | 8 (25.00%) | 24 (75.00%) | ||
| COPD | ||||||
| No | 119 (83.20%) | 24 (16.80%) | P = 0.29 | 32 (21.90%) | 114 (78.10%) | P = 0.56 |
| Yes | 22 (91.70%) | 2 (8.30%) | 4 (16.70%) | 20 (83.30%) | ||
| HCQ | ||||||
| No | 27 (87.10%) | 4 (12.90%) | P = 0.65 | 8 (27.60%) | 21 (72.40%) | P = 0.354 |
| Yes | 114 (83.80%) | 22 (16.20%) | 28 (19.90%) | 113 (80.10%) | ||
| TM | ||||||
| No | 117 (84.80%) | 21 (15.20%) | P = 0.78 | 28 (20.30%) | 110 (79.70%) | P = 0.557 |
| Yes | 24 (82.80%) | 5 (17.20%) | 8 (25.00%) | 24 (75.00%) | ||
| SD | ||||||
| No | 115 (83.30%) | 23 (16.70%) | P = 0.39 | 32 (22.90%) | 108 (77.10%) | P = 0.247 |
| Yes | 26 (89.70%) | 3 (10.30%) | 4 (13.30%) | 26 (86.70%) | ||
| AC | ||||||
| No | 115 (85.80%) | 19 (14.20%) | P = 0.318 | 25 (18.40%) | 111 (81.60%) | P = 0.075 |
| Yes | 26 (78.80%) | 7 (21.20%) | 11 (32.40%) | 23 (67.60%) | ||
DM: diabetes mellitus; HTN: hypertension; CKD: chronic kidney disease; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; HCQ: hydroxychloroquine; TM: tocilizumab; SD: steroid; AC: anticoagulation.